Gala Pharmaceutical Inc. Increase (Decrease) in Deferred Compensation
Gala Pharmaceutical Inc. reported Increase (Decrease) in Deferred Compensation of $172.50 thousand for the 9-month period ending 2018-08-31, per its 10-Q filed 2018-10-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCompensation · last filed 2018-10-26
- Gala Pharmaceutical Inc. increase (decrease) in deferred compensation for the quarter ending 2018-08-31 was $112.50K, a 275.00% increase year-over-year.
- Gala Pharmaceutical Inc. increase (decrease) in deferred compensation for the quarter ending 2018-05-31 was $60.00K, a 87.76% decline year-over-year.
- Gala Pharmaceutical Inc. increase (decrease) in deferred compensation for the quarter ending 2017-08-31 was $30.00K.
- Gala Pharmaceutical Inc. increase (decrease) in deferred compensation for the quarter ending 2017-05-31 was $490.00K.
| Period end | Increase (Decrease) in Deferred Compensation 3 month | Increase (Decrease) in Deferred Compensation 6 month | Increase (Decrease) in Deferred Compensation 9 month |
|---|---|---|---|
| 2018-08-31 | $112.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $172.50K derived: sum of 2 quarters · filed 2018-10-26 | $172.50K 10-Q · filed 2018-10-26 |
| 2018-05-31 | $60.00K 10-Q · filed 2018-08-01 | $60.00K 10-Q · filed 2018-08-01 | |
| 2017-08-31 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $520.00K derived: sum of 2 quarters · filed 2018-10-26 | $520.00K 10-Q · filed 2018-10-26 |
| 2017-05-31 | $490.00K 10-Q · filed 2018-08-01 | $490.00K 10-Q · filed 2018-08-01 |